I am a wide achiever who is comfortable with ambiguity.

My professional interests and experience lay at the intersection of health (prevention, nutrition), technology (body sensors, real-time analytics), entrepreneurship and politics. I am particularly attracted to start up and turn-around opportunities.

—

The existing funding model supporting health care delivery encourages innovation and development in favour of the most costly treatment interventions. The more elaborate and involved your treatment, the more you can charge.

In the future, outcome-based funding models will be established that encourage the least costly, most effective treatments. A bounty will be offered for a particular health outcome in a particular individual or population. The cheaper this outcome costs to achieve, the more profit will be made.

—

Chronic disease is a phenomenon borne out of the economics of the modern food system. In the economic and political context of a health sector driven ultimately by profit, there are two broad responses being considered:

1) Primary prevention – government imposed restrictions on trade expected to deliver downstream health financing dividends

2) Secondary prevention and treatment – health sector delivered amelioration (not cure) of chronic illness.

How is it that we now live in a world dominated by enterprises that profit from directly harming human health?

Particularly in a sector like health care, why is it so difficult to profit from improving human health?

best practice is nothing. personalised improvement, optimization is everything.

 

we need a health system that learns, evolves and adapts to what’s before it, not what history has laden it with.